Download PDF
Thromb Haemost 1997; 78(01): 497-500
DOI: 10.1055/s-0038-1657576
Metallo proteinases and vascular biology
Schattauer GmbH Stuttgart

Membrane-Type Matrix Metalloproteinases (MT-MMPs) in Cell Invasion

Hiroshi Sato
Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
,
Yasunori Okada
1   Department of Molecular Immunology and Pathology, Cancer Research Institute, Kanazawa University, Kanazawa,Japan
,
Motoharu Seiki
Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Liotta LA, Steeg PS, and Stetler-Stevenson WG. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327-336
    CrossrefPubMedGoogle Scholar
  • 2 Tryggvason K, Hoyhtya M, and Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res. Treat 1993; 24: 209-218
    PubMedGoogle Scholar
  • 3 Brannstrom M, Woessner Jr. JF, Koos RD, Sear CH, and LeMaire WJ. Inhibitors of mammalian tissue collagenase and metalloproteinases suppress ovaluation in the perfused rat ovary. Endocrinology 1988; 122: 1715-1721
    CrossrefPubMedGoogle Scholar
  • 4 Brenner CA, Adler RR, Rappolee DA, Pedersen RA, and Werb Z. Genes for Extracellular Matrix-Degrading Metalloproteinases and their Inhibitor, TIMP, Are Expressed During Early Mammalian Development. Genes Develop 1983; 3: 848-859
    PubMedGoogle Scholar
  • 5 Nakanishi Y, Gugiura F, Kishi J.-L, and Hayakawa T. Collagenase inhibitor stimulates cleft formation during early morphogenesis of mouse salivary gland. Dev. Biol 1986; 113: 201-206
    CrossrefPubMedGoogle Scholar
  • 6 Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, and Seiki M. Expression of genes encoding type IV collagen- degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 07: 77-83
    PubMedGoogle Scholar
  • 7 Tsuchiya Y, Endo Y, Sato H, Okada Y, Mai M, Sasaki T, and Seiki M. Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos. Int. J. Cancer 1994; 56: 46-51
    PubMedGoogle Scholar
  • 8 Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 1990; 6: 121-125
    CrossrefPubMedGoogle Scholar
  • 9 Brown PD, Levy AT, Margulies IM, Liotta LA, and Stetler Stevenson WG. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 1993; 50: 6184-6191
    PubMedGoogle Scholar
  • 10 Brown PD, Bloxidge RE, Anderson E, and Howell A. Expression of activated gelatinase in human invasive breast carcinoma. Clin. Exp. Metastasis. 1993; 11: 183-189
    CrossrefPubMedGoogle Scholar
  • 11 Brown PD, Bloxidge RE, Stuart NS A, Gatter KC, and Carmichael J. Association between expression of activated 72-Kilodaloton gelatinase and tumor spread in non-small-cell lung carcinoma. J. Natl. Cancer Inst. 1993; 85: 574-578
    CrossrefPubMedGoogle Scholar
  • 12 Azzam HS, Arand G, Lippman ME. and Thompson, E. W. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 activation. J. Natl. Cancer Inst. 1993; 85: 1758-1764
    CrossrefPubMedGoogle Scholar
  • 13 Yamagata S, Yoshii Y, Suh JG, Tanaka R, and Shimizu S. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett. 1991; 59: 51-55
    CrossrefPubMedGoogle Scholar
  • 14 Strongin AY, Marmer BL, Grant GA, and Goldberg GI. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 1993; 268: 14033-14039
    PubMedGoogle Scholar
  • 15 Overall CM, and Sodek J. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J. Biol. Chem. 1990; 265: 21141-21151
    PubMedGoogle Scholar
  • 16 Ward RV, Atkinson SJ, Slocombe PM, Docherty AJ, Reynolds JJ, and Murphy G. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta. 1991; 1079: 242-246
    CrossrefPubMedGoogle Scholar
  • 17 Atkinson SJ, Ward RV, Reynolds JJ, and Murphy G. Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. Biochem. J. 1992; 288: 605-611
    CrossrefPubMedGoogle Scholar
  • 18 Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, and Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994; 370: 61-65
    CrossrefPubMedGoogle Scholar
  • 19 Will H, and Hinzmann B. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment, Eur. J. Biochem 1995; 231: 602-608
    CrossrefPubMedGoogle Scholar
  • 20 Takino T, Sato H, Shinagawa A, and Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family, J. Biol. Chem 1995; 270: 23013-23020
    CrossrefPubMedGoogle Scholar
  • 21 Puente XS, Pendas AM, Llano E, Velasco G, and Lopez Otin C. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer. Res 1996; 56: 944-949
    PubMedGoogle Scholar
  • 22 Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, and Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990; 348: 699-704
    CrossrefPubMedGoogle Scholar
  • 23 Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, and Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase - Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995; 270: 5331-5338
    CrossrefPubMedGoogle Scholar
  • 24 Yu M, Sato H, Seiki M, and Thompson EW. Complex regulation of membrane-type metalloproteinase expression and matrix metalloproterinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res. 1995; 55: 3272-3277
    PubMedGoogle Scholar
  • 25 Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, and Seiki M. Cell surface binding and activation of gelatinase A induced by expression of membrane- type-1-matrix metalloproteinase (MT1-MMP), FEBS. Lett 1996; 385: 238-240
    PubMedGoogle Scholar
  • 26 Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, and Murphy G. Intermo- lecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 1995; 270: 23013-23020
    CrossrefPubMedGoogle Scholar
  • 27 Takino T, Sato H, Yamamoto E, and Seiki M. Cloning of a gene potentially encoding a novel matrix metalloproteinase having a trans-membrane domain at the C-terminus. Gene 1995; 115: 293-298
    PubMedGoogle Scholar
  • 28 Kinoh A, Sato H, Tsunezuka Y, Okada YKawashima, and Seiki M. MT-MMP, the cell surface activator of proMMP-2 (progelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell Science 1996; 109: 953-959
    PubMedGoogle Scholar
  • 29 Nomura H, Sato H, Seiki M, Mai M, and Okada Y. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 1995; 55: 3263-3266
    PubMedGoogle Scholar
  • 30 Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, and Seiki M. Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J. Cancer 1995; 64: 355-359
    CrossrefPubMedGoogle Scholar
  • 31 Okada A, Bellocq JP, Rouyer N, Chenard MP, Rio M, Chambon P, and Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas, Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 2730-2734
    PubMedGoogle Scholar
  • 32 Brooks PC, Stromblad S, Sanders LC, von Schalscha TL, Aimes RT, Stetler Stevenson WG, Quigley JP, and Cheresh DA. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin avb3. Cell 1996; 85: 683-693
    CrossrefPubMedGoogle Scholar
  • 33 Mignon C, Okada A, Mattei MG, and Basset P. Assignment of the human membrane-type matrix metalloproteinase (MMP-14) gene to 14q 11 -12 by in situ hybridization. Genomics 1995; 28: 360-361
    CrossrefPubMedGoogle Scholar
  • 34 Sato H, Takino T, and Seiki M. Assignment of the human genes for membrane-type-1, -2 and -3 matrix metalloproteinases to 14ql2.2, 16q 12. 2-21 and 8q21, respectively by in situ hybridization. Genomics. (in press)
    Google Scholar
  • 35 Young TN, Pizzo SV, and Stack MS. A plasma membrane-associated component of ovarian adenocarcinoma cells enhances the catalytic efficiency of matrix metalloproteinase-2. J. Biol. Chem. 1995; 270: 999-1002
    CrossrefPubMedGoogle Scholar
  • 36 Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, and Okada Y. Membrane-type 1-matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. (in press)
    Google Scholar
  • 37 Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, and Dano K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am. J. Pathol. 1991; 138: 1059-1067
    PubMedGoogle Scholar